These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7797019)

  • 1. Aquaretic effect of the kappa-opioid agonist RU 51599 in cirrhotic rats with ascites and water retention.
    Bosch-Marcé M; Jiménez W; Angeli P; Leivas A; Clària J; Graziotto A; Arroyo V; Rivera F; Rodés J
    Gastroenterology; 1995 Jul; 109(1):217-23. PubMed ID: 7797019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two aquaretic drugs (niravoline and OPC-31260) in cirrhotic rats with ascites and water retention.
    Bosch-Marcé M; Poo JL; Jiménez W; Bordas N; Leivas A; Morales-Ruiz M; Muñoz RM; Pérez M; Arroyo V; Rivera F; Rodés J
    J Pharmacol Exp Ther; 1999 Apr; 289(1):194-201. PubMed ID: 10087004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal and haemodynamic responses to a novel kappa opioid receptor agonist, niravoline (RU 51,599), in rats with cirrhosis.
    Moreau R; Cailmail S; Hamon G; Lebrec D
    J Gastroenterol Hepatol; 1996 Sep; 11(9):857-63. PubMed ID: 8889966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aquaretic effects of niravoline, a kappa-opioid agonist, in patients with cirrhosis.
    Gadano A; Moreau R; Pessione F; Trombino C; Giuily N; Sinnassamy P; Valla D; Lebrec D
    J Hepatol; 2000 Jan; 32(1):38-42. PubMed ID: 10673065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the V1a/V2-AVP receptor antagonist, Conivaptan, on renal water metabolism and systemic hemodynamics in rats with cirrhosis and ascites.
    Fernández-Varo G; Ros J; Cejudo-Martín P; Cano C; Arroyo V; Rivera F; Rodés J; Jiménez W
    J Hepatol; 2003 Jun; 38(6):755-61. PubMed ID: 12763368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Aquaretic agents].
    Jiménez W
    Nefrologia; 2002; 22 Suppl 5():52-5. PubMed ID: 12107918
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term aquaretic efficacy of a selective nonpeptide V(2)-vasopressin receptor antagonist, SR121463, in cirrhotic rats.
    Jiménez W; Gal CS; Ros J; Cano C; Cejudo P; Morales-Ruiz M; Arroyo V; Pascal M; Rivera F; Maffrand JP; Rodés J
    J Pharmacol Exp Ther; 2000 Oct; 295(1):83-90. PubMed ID: 10991964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased vasopressin-mediated renal water reabsorption in rats with compensated liver cirrhosis.
    Jonassen TE; Nielsen S; Christensen S; Petersen JS
    Am J Physiol; 1998 Aug; 275(2):F216-25. PubMed ID: 9691010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the water diuretic activity of kappa receptor agonists and a vasopressin receptor antagonist in dogs.
    Brooks DP; Valente M; Petrone G; Depalma PD; Sbacchi M; Clarke GD
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1176-83. PubMed ID: 9067301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of solute-free water retention in experimental ascitic cirrhosis: is vasopressin the only culprit?
    Sansoè G; Aragno M; Mastrocola R; Parola M
    Clin Sci (Lond); 2016 Jan; 130(2):117-24. PubMed ID: 26519424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kappa opioid-induced diuresis in female vs. male rats.
    Craft RM; Ulibarri CM; Raub DJ
    Pharmacol Biochem Behav; 2000 Jan; 65(1):53-9. PubMed ID: 10638636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of kappa opioid agonist RU 51599 on osmotic and non-osmotic stimulated arginine vasopressin release and gene regulation in small cell lung carcinoma cells.
    Kim JK; Summer SN; Schrier RW
    Neuropeptides; 1997 Oct; 31(5):423-9. PubMed ID: 9413018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kappa opiate agonist RU 51599 inhibits vasopressin gene expression and osmotically-induced vasopressin secretion in vitro.
    Rossi NF; Kim JK; Summers SN; Schrier RW
    Life Sci; 1997; 61(23):2271-82. PubMed ID: 9408050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aquaretic agents: a new potential treatment of dilutional hyponatremia in cirrhosis.
    Ginès P; Jiménez W
    J Hepatol; 1996 Apr; 24(4):506-12. PubMed ID: 8738740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of niravoline (RU 51599), a selective kappa-opioid receptor agonist on intracranial pressure in gradually expanding extradural mass lesion.
    Bemana I; Nagao S
    J Neurotrauma; 1998 Feb; 15(2):117-24. PubMed ID: 9512087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of V1-vasopressin receptor blockade on arterial pressure in conscious rats with cirrhosis and ascites.
    Claria J; Jiménez W; Arroyo V; La Villa G; López C; Asbert M; Castro A; Gaya J; Rivera F; Rodés J
    Gastroenterology; 1991 Feb; 100(2):494-501. PubMed ID: 1824629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal relationship between the impairment of free water excretion and antidiuretic hormone hypersecretion in rats with experimental cirrhosis.
    Camps J; Solá J; Arroyo V; Pérez-Ayuso RM; Gaya J; Rivera F; Rodés J
    Gastroenterology; 1987 Sep; 93(3):498-505. PubMed ID: 3609659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of the hydroosmotic effect of vasopressin normalizes water excretion in cirrhotic rats.
    Claria J; Jiménez W; Arroyo V; Guarner F; López C; La Villa G; Asbert M; Rivera F; Rodés J
    Gastroenterology; 1989 Nov; 97(5):1294-9. PubMed ID: 2792662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Renal effects of the chronic inhibition of nitric oxide synthesis in cirrhotic rats with ascites].
    Ortiz MC; Fortepiani LA; Martínez-Salgado C; Eleno N; Atucha NM; López-Novoa JM; García-Estañ J
    Nefrologia; 2001; 21(6):556-64. PubMed ID: 11881425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained aquaretic effect of the V2-AVP receptor antagonist, RWJ-351647, in cirrhotic rats with ascites and water retention.
    Ros J; Fernández-Varo G; Muñoz-Luque J; Arroyo V; Rodés J; Gunnet JW; Demarest KT; Jiménez W
    Br J Pharmacol; 2005 Nov; 146(5):654-61. PubMed ID: 16113688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.